Document Detail


Impact of 6-month angiographic restenosis inside bare-metal stents on long-term clinical outcome in patients with coronary artery disease.
MedLine Citation:
PMID:  17827816     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This study enrolled 536 patients who underwent successful coronary stenting with bare-metal stents and 6-month angiographic follow-up examinations between 1998 and 2000. Baseline characteristics and angiographic and procedural parameters for these patients were obtained. Primary endpoints were all-cause mortality and nonfatal myocardial infarction. Patients were assigned to instent restenosis or non-instent restenosis groups based on 6-month angiographic follow-up results. Restenosis inside a bare-metal stent was defined as more than 50% stenosis at the intervention site. In total, 178 (33.2%) patients had restenosis inside bare-metal stents, while 358 (66.8%) patients were without. At mean follow-up of 56.8 +/- 20.3 months, 36 (6.7%) patients had a primary endpoint event while 500 (93.3%) patients had no primary endpoint event. Survival rates for patients free from primary endpoints in the instent restenosis and non-instent restenosis groups were 96.0 versus 99.4% at 1 year and 89.8% versus 94.8% at 5 years, respectively (P = 0.0033). Survival rates for patients free of all-cause mortality in the instent restenosis and non-instent restenosis groups were 96.0% versus 99.4% at 1 year and 91.6% versus 96.3% at 5 years, respectively (P = 0.0079). Multivariate Cox regression analysis showed that restenosis inside bare-metal stents was an independent predictor of primary endpoint events (odds ratio: 2.053; 95% CI: 1.048-4.022; P = 0.036) and was a predictor of total mortality with borderline significance (odds ratio: 2.036; 95% CI: 0.936-4.431; P = 0.073). In conclusion, in this study, restenosis inside bare-metal stents at 6-month angiographic follow-up was an independent predictor of long-term outcome-all-cause mortality and nonfatal myocardial infarction. Thus, this study provides clinical evidence that patients with restenosis inside bare-metal stents at 6-month angiographic follow-up likely warrant aggressive follow-up.
Authors:
Yung-Lung Chen; Mien-Cheng Chen; Chiung-Jen Wu; Hon-Kan Yip; Chih-Yuan Fang; Yuan-Kai Hsieh; Chien-Jen Chen; Cheng-Hsu Yang; Hsueh-Wen Chang
Related Documents :
12521626 - Effect of angiotensin-converting enzyme inhibition on restenosis after coronary stenting.
13678916 - Angiographic variables predict increased risk for adverse ischemic events after coronar...
12479916 - Required treatment margin for coronary endovascular brachytherapy with iridium-192 seed...
18420096 - A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and ...
16480976 - Class iii effects of dofetilide and arrhythmias are modulated by [k+]o in an in vitro m...
20193036 - Injectable cardiac tissue engineering for the treatment of myocardial infarction.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International heart journal     Volume:  48     ISSN:  1349-2365     ISO Abbreviation:  -     Publication Date:  2007 Jul 
Date Detail:
Created Date:  2007-09-10     Completed Date:  2008-04-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101244240     Medline TA:  Int Heart J     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  443-54     Citation Subset:  IM    
Affiliation:
Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, Taiwan, ROC.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Coronary Angiography
Coronary Disease / mortality,  physiopathology*,  radiography,  therapy
Coronary Restenosis / etiology*
Female
Follow-Up Studies
Humans
Male
Middle Aged
Proportional Hazards Models
Stents*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The relationship of chronic angiotensin converting enzyme inhibitor use and coronary collateral vess...
Next Document:  Initial impact of drug-eluting stents on coronary artery bypass grafting.